Relx (NYSE:RELX) Rating Lowered to Hold at StockNews.com

Relx (NYSE:RELX) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday.

Separately, Berenberg Bank downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Friday, March 1st.

Relx Stock Performance

NYSE:RELX opened at $41.45 on Tuesday. The company has a fifty day simple moving average of $42.92 and a two-hundred day simple moving average of $39.77. The company has a debt-to-equity ratio of 1.51, a quick ratio of 0.47 and a current ratio of 0.52. Relx has a 52 week low of $30.10 and a 52 week high of $44.75.

Hedge Funds Weigh In On Relx

Several large investors have recently bought and sold shares of RELX. AEGON ASSET MANAGEMENT UK Plc purchased a new stake in shares of Relx in the fourth quarter valued at about $16,120,000. Invesco Ltd. boosted its stake in shares of Relx by 11.2% during the third quarter. Invesco Ltd. now owns 1,305,950 shares of the technology company’s stock worth $44,011,000 after buying an additional 131,711 shares during the period. Atria Investments Inc boosted its stake in shares of Relx by 10.7% during the third quarter. Atria Investments Inc now owns 58,440 shares of the technology company’s stock worth $1,969,000 after buying an additional 5,635 shares during the period. J.P. Morgan Private Wealth Advisors LLC acquired a new stake in shares of Relx during the third quarter worth about $1,560,000. Finally, Royal Bank of Canada boosted its stake in shares of Relx by 2.9% during the third quarter. Royal Bank of Canada now owns 1,574,752 shares of the technology company’s stock worth $53,070,000 after buying an additional 43,644 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.

About Relx

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.